Extracellular Vesicle-Encapsulated microRNAs and Respiratory Health Among American Indian Participants in the Strong Heart Study.

IF 9.5 1区 医学 Q1 CRITICAL CARE MEDICINE
Chest Pub Date : 2025-01-01 Epub Date: 2024-08-16 DOI:10.1016/j.chest.2024.08.004
Christina M Eckhardt, Haotian Wu, Gabriela Jackson, Marisa H Sobel, Tessa Bloomquist, Adnan Divjan, Hadler da Silva, Lyle G Best, Shelley Cole, Jason Umans, Ying Zhang, Peter de Hoff, Louise C Laurent, Matthew S Perzanowski, Ke Cheng, Andrea A Baccarelli, Tiffany R Sanchez
{"title":"Extracellular Vesicle-Encapsulated microRNAs and Respiratory Health Among American Indian Participants in the Strong Heart Study.","authors":"Christina M Eckhardt, Haotian Wu, Gabriela Jackson, Marisa H Sobel, Tessa Bloomquist, Adnan Divjan, Hadler da Silva, Lyle G Best, Shelley Cole, Jason Umans, Ying Zhang, Peter de Hoff, Louise C Laurent, Matthew S Perzanowski, Ke Cheng, Andrea A Baccarelli, Tiffany R Sanchez","doi":"10.1016/j.chest.2024.08.004","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>American Indian populations have experienced marked disparities in respiratory disease burden. Extracellular vesicle-encapsulated microRNAs (EV-miRNAs) are a novel class of biomarkers that may improve recognition of lung damage in indigenous populations in the United States.</p><p><strong>Research question: </strong>Are plasma EV-miRNAs viable biomarkers of respiratory health in American Indian populations?</p><p><strong>Study design and methods: </strong>The Strong Heart Study is a prospective cohort study that enrolled American Indian patients aged 45 to 74 years. EV-miRNA expression was measured in plasma (1993-1995). Respiratory health outcomes, including prebronchodilator FEV<sub>1</sub>, FVC, and respiratory symptom burden, were ascertained in the same study visit. Club cell secretory protein (CC-16), an antiinflammatory pneumoprotein implicated in COPD pathogenesis, was measured in serum. Linear and logistic regression were used for statistical analyses. Biological pathway analyses were used to elucidate gene targets of significant EV-miRNAs.</p><p><strong>Results: </strong>Among 853 American Indian adults, three EV-miRNAs were associated with FEV<sub>1</sub>, four EV-miRNAs were associated with FVC, and one EV-miRNA was associated with FEV<sub>1</sub>/FVC (P < .05). Increased miR-1294 expression was associated with higher odds of airflow limitation (OR, 1.29; 95% CI, 1.07-1.55), whereas increased expression of miR-1294 (OR, 1.32; 95% CI, 1.07-1.63) and miR-532-5p (OR, 1.57; 95% CI, 1.02-2.40) was associated with higher odds of restriction. Increased miR-451a expression was associated with lower odds of exertional dyspnea (OR, 0.71; 95% CI, 0.59-0.85). Twenty-two EV-miRNAs were associated with serum CC-16 levels (q < 0.05), suggesting that EV-miRNAs may play a role in the pathway linking CC-16 to COPD pathogenesis. A pathway analysis showed key EV-miRNAs targeted biological pathways that modulate inflammation, immunity, and structural integrity in the lungs.</p><p><strong>Interpretation: </strong>Circulating EV-miRNAs are novel mechanistic biomarkers of respiratory health and may facilitate the early detection and treatment of lung damage in American Indian populations that have been disproportionately affected by chronic lung diseases.</p>","PeriodicalId":9782,"journal":{"name":"Chest","volume":" ","pages":"87-97"},"PeriodicalIF":9.5000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11752130/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chest","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.chest.2024.08.004","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/8/16 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CRITICAL CARE MEDICINE","Score":null,"Total":0}
引用次数: 0

Abstract

Background: American Indian populations have experienced marked disparities in respiratory disease burden. Extracellular vesicle-encapsulated microRNAs (EV-miRNAs) are a novel class of biomarkers that may improve recognition of lung damage in indigenous populations in the United States.

Research question: Are plasma EV-miRNAs viable biomarkers of respiratory health in American Indian populations?

Study design and methods: The Strong Heart Study is a prospective cohort study that enrolled American Indian patients aged 45 to 74 years. EV-miRNA expression was measured in plasma (1993-1995). Respiratory health outcomes, including prebronchodilator FEV1, FVC, and respiratory symptom burden, were ascertained in the same study visit. Club cell secretory protein (CC-16), an antiinflammatory pneumoprotein implicated in COPD pathogenesis, was measured in serum. Linear and logistic regression were used for statistical analyses. Biological pathway analyses were used to elucidate gene targets of significant EV-miRNAs.

Results: Among 853 American Indian adults, three EV-miRNAs were associated with FEV1, four EV-miRNAs were associated with FVC, and one EV-miRNA was associated with FEV1/FVC (P < .05). Increased miR-1294 expression was associated with higher odds of airflow limitation (OR, 1.29; 95% CI, 1.07-1.55), whereas increased expression of miR-1294 (OR, 1.32; 95% CI, 1.07-1.63) and miR-532-5p (OR, 1.57; 95% CI, 1.02-2.40) was associated with higher odds of restriction. Increased miR-451a expression was associated with lower odds of exertional dyspnea (OR, 0.71; 95% CI, 0.59-0.85). Twenty-two EV-miRNAs were associated with serum CC-16 levels (q < 0.05), suggesting that EV-miRNAs may play a role in the pathway linking CC-16 to COPD pathogenesis. A pathway analysis showed key EV-miRNAs targeted biological pathways that modulate inflammation, immunity, and structural integrity in the lungs.

Interpretation: Circulating EV-miRNAs are novel mechanistic biomarkers of respiratory health and may facilitate the early detection and treatment of lung damage in American Indian populations that have been disproportionately affected by chronic lung diseases.

细胞外囊泡封装的 microRNA 与强心研究中美国印第安人的呼吸系统健康。
背景:美国印第安人在呼吸系统疾病负担方面存在明显差异。细胞外囊包被的微RNA(EV-miRNA)是一类新型生物标志物,可提高对土著居民肺损伤的识别能力:研究问题:血浆 EV-miRNA 是否是美国印第安人呼吸系统健康的可行生物标志物?强心研究是一项前瞻性队列研究,研究对象为 45-74 岁的美国印第安人。该研究测量了血浆中 EV-miRNA 的表达(1993-1995 年)。在同一研究访问中确定了呼吸系统健康状况,包括支气管扩张前 1 秒用力呼气容积(FEV1)、用力肺活量(FVC)和呼吸系统症状负担。对血清中的俱乐部细胞分泌蛋白(CC-16)进行了测定,这是一种与慢性阻塞性肺病发病机制有关的抗炎性肺炎蛋白。统计分析采用线性回归和逻辑回归。生物通路分析用于阐明重要 EV-miRNA 的基因靶标:结果:在 853 名美国印第安成年人中,3 个 EV-miRNA 与 FEV1 相关,4 个 EV-miRNA 与 FVC 相关,1 个 EV-miRNA 与 FEV1/FVC 相关(P解释:循环中的 EV-miRNA 与 FEV1 相关):循环中的 EV-miRNA 是呼吸系统健康的新型机理生物标志物,可能有助于早期检测和治疗美国印第安人的肺部损伤,这些人受慢性肺部疾病的影响尤为严重。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Chest
Chest 医学-呼吸系统
CiteScore
13.70
自引率
3.10%
发文量
3369
审稿时长
15 days
期刊介绍: At CHEST, our mission is to revolutionize patient care through the collaboration of multidisciplinary clinicians in the fields of pulmonary, critical care, and sleep medicine. We achieve this by publishing cutting-edge clinical research that addresses current challenges and brings forth future advancements. To enhance understanding in a rapidly evolving field, CHEST also features review articles, commentaries, and facilitates discussions on emerging controversies. We place great emphasis on scientific rigor, employing a rigorous peer review process, and ensuring all accepted content is published online within two weeks.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信